Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1215 Triple Negative Breast Neoplasms 284 Ovarian Neoplasms 262 Carcinoma, Non-Small-Cell Lung 249 Colorectal Neoplasms 190 Pancreatic Neoplasms 168 Stomach Neoplasms 164 Neoplasm Metastasis 156 Neoplasms 155 Lung Neoplasms 144 Prostatic Neoplasms 143 Melanoma 132 Carcinoma, Renal Cell 103 Squamous Cell Carcinoma of Head and Neck 102 Endometrial Neoplasms 99 Head and Neck Neoplasms 88 Colonic Neoplasms 82 Urinary Bladder Neoplasms 79 Uterine Cervical Neoplasms 77 Esophageal Neoplasms 76 Sarcoma 72 Breast Neoplasms, Male 68 Small Cell Lung Carcinoma 66 Carcinoma, Hepatocellular 60 Carcinoma, Ovarian Epithelial 58 Kidney Neoplasms 47 Carcinoma, Transitional Cell 41 Rectal Neoplasms 35 Fallopian Tube Neoplasms 34 Liver Neoplasms 32

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pre-menopausal Breast Cancer × Breast × Clear all

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡